Jean Forcione

Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada.

Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada.

Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million.

Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million.

Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million.

Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Part of Novo Nordisk Fonden, BBI Group Holdco Ltd. is a British company that develops and distributes diagnostic equipment. The company is based in Cardiff, UK. Founded in 2020. BBI Group Holdco was acquired by Novo Holdings AS (Denmark) on July 23, 2021 for $564.78 million.

Orion Biotechnology Canada Ltd. operates as pharmaceutical company. The company was founded by Rudolf Bom in 2011 and is headquartered in Ottawa, Canada.